Skip to main content

NICE TAs

13/05/2025
TA1062: Erdafitinib for treating unresectable or metastatic urothelial cancer with FGFR3 alterations after a PD-1 or PD-L1 inhibitor
08/05/2025
TA1060: Osimertinib with pemetrexed and platinum-based chemotherapy for untreated EGFR mutation-positive advanced non-small-cell lung cancer
07/05/2025
TA1059: Brentuximab vedotin in combination for untreated stage 3 or 4 CD30-positive Hodgkin lymphoma
16/04/2025
TA1056: Molnupiravir for treating COVID-19
16/04/2025
TA1055: Rucaparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy
16/04/2025
TA1057: Relugolix–estradiol–norethisterone for treating symptoms of endometriosis
15/04/2025
TA1054: Ruxolitinib for treating acute graft versus host disease that responds inadequately to corticosteroids in people 12 years and over
15/04/2025
TA1053: Cladribine for treating active relapsing forms of multiple sclerosis
02/04/2025
TA1051: Efanesoctocog alfa for treating and preventing bleeding episodes in haemophilia A in people 2 years and over
27/03/2025
TA1050: Fenfluramine for treating seizures associated with Lennox–Gastaut syndrome in people 2 years and over
27/03/2025
TA1048: Lisocabtagene maraleucel for treating relapsed or refractory large B-cell lymphoma after first-line chemoimmunotherapy when a stem cell transplant is suitable
27/03/2025
TA1049: Blinatumomab with chemotherapy for consolidation treatment of Philadelphia-chromosome-negative CD19-positive minimal residual disease-negative B-cell precursor acute lymphoblastic leukaemia
12/03/2025
TA1046: Zolbetuximab with chemotherapy for untreated claudin-18.2-positive HER2-negative unresectable advanced gastric or gastro-oesophageal junction adenocarcinoma
05/03/2025
TA1045: 12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites
26/02/2025
TA1043: Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resection
26/02/2025
TA1044: Exagamglogene autotemcel for treating severe sickle cell disease in people 12 years and over
19/02/2025
TA1042: Selpercatinib for previously treated RET fusion-positive advanced non-small-cell lung cancer
19/02/2025
TA1041: Durvalumab with etoposide and either carboplatin or cisplatin for untreated extensive-stage small-cell lung cancer
02/10/2024
TA1009: Latanoprost–netarsudil for previously treated primary open-angle glaucoma or ocular hypertension
17/09/2024
TA1007: Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer
Follow AWTTC: